Recovery of CMV and EBV immunity
Days from T-cell infusion . | CMV* . | EBV* . |
|---|---|---|
| UPN25 | ||
| -77 | 1983 | 7 |
| 15 | 131 | 33 |
| 50 | 840 | 20 |
| 86 | 550 | 45 |
| 251 | 528 | 23 |
| 285 | 598 | 2 |
| UPN23 | ||
| -92 | — | 85 |
| 15 | — | 13 |
| 43 | — | 43 |
| 73 | — | 30 |
Days from T-cell infusion . | CMV* . | EBV* . |
|---|---|---|
| UPN25 | ||
| -77 | 1983 | 7 |
| 15 | 131 | 33 |
| 50 | 840 | 20 |
| 86 | 550 | 45 |
| 251 | 528 | 23 |
| 285 | 598 | 2 |
| UPN23 | ||
| -92 | — | 85 |
| 15 | — | 13 |
| 43 | — | 43 |
| 73 | — | 30 |
Spot-forming units are shown as the average of triplicate wells per 1 × 106 PBMCs at various intervals before and after the T-cell infusion. Cells were stimulated for 18 hours with viral lysates as described in “Patients, materials, and methods.” — indicates not determined.